4/15
01:26 pm
azn
AstraZeneca PLC (NASDAQ: AZN) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $75.00 price target on the stock.
Low
Report
AstraZeneca PLC (NASDAQ: AZN) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $75.00 price target on the stock.
2/13
08:36 am
azn
AstraZeneca PLC (NASDAQ: AZN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Low
Report
AstraZeneca PLC (NASDAQ: AZN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
2/13
06:12 am
azn
Rating for AZN
Low
Report
Rating for AZN
2/13
04:40 am
azn
AstraZeneca upgraded to Buy from Neutral at UBS
Low
Report
AstraZeneca upgraded to Buy from Neutral at UBS
2/12
07:15 am
azn
AstraZeneca PLC (NASDAQ: AZN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Low
Report
AstraZeneca PLC (NASDAQ: AZN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
2/12
07:15 am
azn
AstraZeneca PLC (NASDAQ: AZN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
Low
Report
AstraZeneca PLC (NASDAQ: AZN) is now covered by analysts at Morgan Stanley. They set an "overweight" rating on the stock.
2/12
04:31 am
azn
AstraZeneca initiated with an Overweight at Morgan Stanley
Low
Report
AstraZeneca initiated with an Overweight at Morgan Stanley
2/12
04:31 am
azn
AstraZeneca initiated with an Overweight at Morgan Stanley
Low
Report
AstraZeneca initiated with an Overweight at Morgan Stanley